The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse
Open accessAbstract
Duchenne muscular dystrophy (DMD) is a severe muscle wasting disease arising from defects in the dystrophin gene, typically nonsense or frameshift mutations, that preclude the synthesis of a functional protein. A milder, allelic version of the disease, Becker muscular dystrophy, generally arises from in-frame deletions that allow synthesis of a shorter but still semifunctional protein. Therapies to introduce functional dystrophin into dystrophic tissue through either cell or gene replacement have not been successful to date. We report an alternative approach where 2′- O -methyl antisense oligoribonucleotides have been used to modify processing of the dystrophin pre-mRNA in the mdx mouse model of DMD. By targeting 2′- O -methyl antisense oligoribonucleotides to block motifs involved in normal dystrophin pre-mRNA splicing, we induced excision of exon 23, and the mdx nonsense mutation, without disrupting the reading frame. Exon 23 skipping was first optimized in vitro in transfected H-2K b -tsA58 mdx myoblasts and then induced in vivo . Immunohistochemical staining demonstrated the synthesis and correct subsarcolemmal localization of dystrophin and γ-sarcoglycan in the mdx mouse after intramuscular delivery of antisense oligoribonucleotide:liposome complexes. This approach should reduce the severity of DMD by allowing a dystrophic gene transcript to be modified, such that it can be translated into a Becker-dystrophin-like protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
X chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
Koenig, M., Monaco, A. P., & Kunkel, L. M. (1988) · Cell · doi:10.1016/0092-8674(88)90383-2 · Cited by 1,538
Monaco, A. P., Bertelson, C. J., Liechti-Gallati, S., Moser, H., & Kunkel, L. M. (1988) · Genomics · doi:10.1016/0888-7543(88)90113-9 · Cited by 1,210
Hoffman, E. P., Fischbeck, K. H., Brown, R. H., Johnson, M., Medori, R., Loire, J. D., Harris, J. B., Waterston, R., Brooke, M., Specht, L., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182104 · Cited by 927
Characterization of oligonucleotide transport into living cells.
Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S., & Neckers, L. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3474 · Cited by 734
The structural and functional diversity of dystrophin
Ahn, A. H., & Kunkel, L. M. (1993) · Nature Genetics · doi:10.1038/ng0493-283 · Cited by 650
Very mild muscular dystrophy associated with the deletion of 46% of dystrophin
England, S. B., Nicholson, L. V. B., Johnson, M. A., Forrest, S. M., Love, D. R., Zubrzycka-Gaarn, E. E., Bulman, D. E., Harris, J. B., & Davies, K. E. (1990) · Nature · doi:10.1038/343180a0 · Cited by 623
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?
Yakubov, L. A., Deeva, E. A., Zarytova, V. F., Ivanova, E. M., Ryte, A. S., Yurchenko, L. V., & Vlassov, V. V. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6454 · Cited by 509
Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs
Acsadi, G., Dickson, G., Love, D. R., Jani, A., Walsh, F. S., Gurusinghe, A., Wolff, J. A., & Davies, K. E. (1991) · Nature · doi:10.1038/352815a0 · Cited by 485
Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
Dominski, Z., & Kole, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8673 · Cited by 426
Sharp, N. J. H., Kornegay, J. N., Van Camp, S. D., Herbstreith, M. H., Secore, S. L., Kettle, S., Hung, W.-Y., Constantinou, C. D., Dykstra, M. J., Roses, A. D., et al. (1992) · Genomics · doi:10.1016/0888-7543(92)90210-j · Cited by 362
Somatic reversion/suppression of the mouse mdx phenotype in vivo
Hoffman, E. P., Morgan, J. E., Watkins, S. C., & Partridge, T. A. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90195-s · Cited by 277
Self-citationMorgan, J. E., Beauchamp, J. R., Pagel, C. N., Peckham, M., Ataliotis, P., Jat, P. S., Noble, M. D., Farmer, K., & Partridge, T. A. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1103 · Cited by 256
Self-citationWilton, S. D., Lloyd, F., Carville, K., Fletcher, S., Honeyman, K., Agrawal, S., & Kole, R. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00010-3 · Cited by 217
Self-citationLu, Q. L., Morris, G. E., Wilton, S. D., Ly, T., Artem'yeva, O. V., Strong, P., & Partridge, T. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.5.985 · Cited by 197
Self-citationSarcoglycans in muscular dystrophy
Hack, A. A., Groh, M. E., & McNally, E. M. (2000) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(20000201/15)48:3/4<167::aid-jemt5>3.0.co;2-t · Cited by 159
Klein, C. J., Coovert, D. D., Bulman, D. E., Ray, P. N., Mendell, J. R., & Burghes, A. H. M. (1992) · PubMed · Cited by 142
Dystrophin in skeletal muscle II. Immunoreactivity in patients with Xp21 muscular dystrophy
Nicholson, L. V. B., Davison, K., Johnson, M. A., Slater, C. R., Young, C., Bhattacharya, S. S., Gardner‐Medwin, D., & Harris, J. B. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90224-4 · Cited by 142
Dystrophin‐positive fibers in duchenne dystrophy: Origin and correlation to clinical course
Fanin, M., Danieli, G. A., Cadaldini, M., et al. (1995) · Muscle & Nerve · doi:10.1002/mus.880181007 · Cited by 72
Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.
Nicholson, L. V. B., Johnson, M. A., Bushby, K. M. D., & Gardner‐Medwin, D. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.5.632 · Cited by 56
Cell and Gene Therapy in Duchenne Muscular Dystrophy
Morgan, J. E. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.2-165 · Cited by 51
Self-citationPetrof, B. J., Acsádi, G., Jani, A., Massie, B., Bourdon, J., Matusiewicz, N., Yang, L., Lochmüller, H., & Karpati, G. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.5.7576685 · Cited by 42
Challenges: Cell transplantation and gene therapy in muscular dystrophy
Morgan, J. E., & Partridge, T. A. (1992) · BioEssays · doi:10.1002/bies.950140913 · Cited by 38
Self-citationDystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype
Morandi, L. O., Mora, M., Confalonieri, V., Barresi, R., Blasi, C. D., Brugnoni, R., Bernasconi, P., Mantegazza, R., Dworzak, F., Antozzi, C. G., et al. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00147-t · Cited by 31
Gene therapy and molecular approaches to the treatment of hereditary muscular disorders
Fletcher, S., Wilton, S. D., & Howell, J. M. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200010000-00008 · Cited by 24
Self-citationSarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?
Matsumura, K., Saito, F., Yamada, H., Hase, A., Sunada, Y., & Shimizu, T. (1999) · PubMed · Cited by 15
Cited by
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Nelson, C. E., Hakim, C. H., Ousterout, D. G., Thakore, P. I., Moreb, E. A., Rivera, R. M. C., Madhavan, S., Pan, X., Ran, F. A., Yan, W. X., et al. (2016) · Science · doi:10.1126/science.aad5143 · Cited by 1,144
Dystrophin and mutations: one gene, several proteins, multiple phenotypes
Muntoni, F., Torelli, S., & Ferlini, A. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00585-4 · Cited by 1,124
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Shen, X., & Corey, D. R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1239 · Cited by 632
Nonsense-mediated decay approaches the clinic
Holbrook, J. A., Neu-Yilik, G., Hentze, M. W., & Kulozik, A. E. (2004) · Nature Genetics · doi:10.1038/ng1403 · Cited by 596
Metadata
- Authors
- Mann, C. J., Honeyman, K., Cheng, A. J., Ly, T., Lloyd, F., Fletcher, S., Morgan, J. E., Partridge, T. A., & Wilton, S. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-12-19
- Volume
- 98
- Issue
- 1
- Pages
- 42-47
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2072847969
- Cited by
- 388
- References
- 28
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.